Venous Thromboembolic Disease Clinical Trial
Official title:
Observational Prospectif Monocentric Registry of Patients Suffering From VIE
Patients with an episode of VTE (DVT and / or PE) have a mortality rate of 16-21% at 1 year after diagnosis. Morbidity associated with VTE is marked by the risk of recurrence, estimated at 30% and estimated at 29% after 8 years of follow post-thrombotic syndrome. For a number of these patients, risk factors have been identified (congenital or acquired thrombophilia, cancer, postpartum, surgery, prolonged immobilization, etc..). In 25-50% of cases, the etiology remains unknown, justifying the need for well-conducted studies to determine other potential risk factors. In addition, the expansion of treatment options with the arrival on the market of new direct oral anticoagulants, allows comparative studies on the effectiveness and frequency of adverse events for each treatment.
n/a
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04414332 -
Registry of Angiovac Procedures In Detail Outcomes Database-RAPID Registry
|
||
| Recruiting |
NCT03206372 -
Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure
|
||
| Recruiting |
NCT03937583 -
Screening for Cancer in Patients With Unprovoked VTE
|
Phase 4 | |
| Completed |
NCT04846725 -
Predictors of Attempted Inferior Vena Cava Filters Retrieval.
|
||
| Completed |
NCT01729559 -
Venous Thromboembolic Prophylaxis After Major Trauma: A Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
|
Phase 4 | |
| Completed |
NCT01466426 -
The Role of FDG-PET/CT Imaging in the Management of Patients With Thromboembolic Disorders (The PETVET Study)
|
N/A | |
| Recruiting |
NCT05150314 -
Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin
|
||
| Active, not recruiting |
NCT05396157 -
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
|
||
| Active, not recruiting |
NCT00691470 -
Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
|
Phase 2/Phase 3 | |
| Completed |
NCT04824118 -
Clotting Parameters After Medical Abortion
|
||
| Recruiting |
NCT03887806 -
Cost Effectiveness Analysis of an Ancillary Study of the REMOTEV Study
|
||
| Not yet recruiting |
NCT06232551 -
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
|
N/A | |
| Recruiting |
NCT05993533 -
Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy
|
||
| Not yet recruiting |
NCT05515549 -
Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients
|
||
| Recruiting |
NCT04211181 -
CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism
|
N/A | |
| Completed |
NCT04818151 -
Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data
|
||
| Recruiting |
NCT05089227 -
Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study
|
Phase 2 | |
| Completed |
NCT03894878 -
Association Between Genetic Variant Scores and Warfarin Effect
|
||
| Completed |
NCT00556426 -
Prospective, Multi-center, Single-arm Study to Assess the Safety of Retrieval of the Recovery G2 Filter.
|
N/A | |
| Not yet recruiting |
NCT04158973 -
CHIPs-VTE Study in Hospitalized Patients With Lung Cancer
|
N/A |